Navigation Links
SALVAT has Completed Patient Enrollment in a Dose Finding Phase II Trial of SVT-40776 for the Treatment of Overactive Bladder
Date:10/9/2007

Results Expected to be Delivered by November 2007

BARCELONA, Spain, October 9 /PRNewswire/ -- This double-blind, placebo-controlled and multi-center Phase II trial includes 332 patients with Overactive Bladder (OAB) and has been conducted at 77 sites in 11 countries (US, Germany, Spain, The Netherlands, Czech Republic, Hungary, Poland, Russia, South Africa, New Zealand and Australia). The company expects to report the results of this trial during November.

The total study treatment duration after screening and baseline has been 4 weeks. Patients have been randomized into one of five treatment arms, which include one placebo, one active control (Tolterodine, 4 mg once daily) and three SVT-40776 groups (once daily administration). The primary endpoint of the trial is the mean change from baseline to last day of treatment in the number of micturitions per day. The trial will also generate tolerability data.

"The successful completion of patient enrollment in this clinical trial represents an important milestone in the development of SVT-40776" said Jordi Julve, CEO.

"We are very excited to look at the data regarding the efficacy and safety of SVT-40776 and to confirm the excellent profile suggested by our previous clinical data. We expect that SVT-40776 will improve the efficacy/tolerability ratio compared to the current available treatments, being the treatment of choice for patients with OAB" continued Mr. Julve.

About SVT-40776

SVT-40776 is a new potent and selective M3 muscarinic antagonist for the treatment of OAB with high bladder/salivary gland selectivity, long half life and low metabolic rate. Compared to oxybutynin, tolterodine, solifenacin and darifenacin, SVT-40776 is the most potent and selective M3 vs M2 yet developed. This profile is expected to give SVT-40776 an improved efficacy and tolerability, increasing the benefit/risk ratio.

About SALVAT

SALVAT is an independent, privately owned, Sp
'/>"/>

SOURCE SALVAT
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method
2. Quantitation of GAD67 Gene Expression in Prefrontal Cortex of Schizophrenia Patients Using the iCycler iQ Detection System and Molecular Beacons, Rev A
3. Milwaukee takes another step in electronic patient data exchange
4. What patients want: A story of choice, clinical trials & evidence-based medicine
5. GE partner allows real-time access to patient data
6. Sun, TeraMedica solution aimed at doctor-patient relationship
7. Interview: Dr. William Yasnoff on patient-centric IT
8. Video game technology could improve physician-patient interactions
9. GE and Intermountain want to streamline nationwide patient data
10. Human factors and IT: Designing for patient safety
11. The challenges of maintaining patient privacy and delivering secure clinical information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Israel, December 2 Gamida Cell announced today,a ... and,efficacy of a gene therapy product which combines ... The product may have potential to,treat inherited anemias ... Gamida Cell is developing a series of ...
(Date:12/2/2009)... -- Simcere Pharmaceutical Group,("Simcere" or the "Company") (NYSE: ... in the development, manufacturing, and marketing of branded,generic ... 105 of,its drugs have been included in China,s ... China,s Ministry of Human Resources and Social,Security on ...
(Date:12/2/2009)... life sciences, ranked Photometrics’ Evolve “Intelligent” EMCCD camera fourth among ... ... (PRWEB) December 2, 2009 -- The ... designer and manufacturer of high-performance CCD and EMCCD cameras for ...
(Date:12/1/2009)... PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today announced ... of approximately $57 million, as compared with $69 million for ... results was the first of two installment payments of $12.5 ... results was a one-time $1.8 million payment from Genentech for ...
Breaking Biology Technology:Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
... China, May 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech ... device research,and development outsourcing company with operations ... announced that it has appointed Dr. Peng ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), Prior ...
... In Europe, Less Screening and Treatment, and an Apparent Higher ... of Hip Fracture Than in North America and Australia, ... one in four women surveyed from Europe, North America, and,Australia ... of 45,years. Among women considered to be at high risk ...
... Inc. (Nasdaq:,BHRT) announced that on May 21, 2008 ... (the "Nasdaq Letter") advising that, for the last ... listed securities,had been below the minimum $50,000,000 requirement ... to Nasdaq Marketplace Rule,4450(b)(1)(A). Furthermore, Nasdaq stated that ...
Other Biology Technology:WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 2Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 3Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World 4Bioheart, Inc. Reports Receipt of Notification from NASDAQ Regarding Non-Compliance with Continued Listing Requirements 2
(Date:12/3/2009)... to learn new information and adapt to changes in our ... to lie in the minute junctions where nerve cells communicate, ... researchers. The study is published online this week in the ... Wen-Biao Gan, PhD, associate professor of physiology and neuroscience at ...
(Date:12/3/2009)... infections are caused by many bacterial cells that signal each ... sensing because many bacteria must be present to start the ... that the very first stage of staph infection, when bacteria ... a single cell and that this individual process can be ...
(Date:12/3/2009)... measured CO2 levels for the past three years in ... area near Valladolid. The results, which are the first ... the levels rose "significantly" between 2002 and 2005. , ... to find out about carbon dioxide (CO2) levels, and ...
Breaking Biology News(10 mins):Lifelong memories linked to stable nerve connections 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 1The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 2The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 3The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 4The Ensign Group Acquires Dallas Skilled Nursing Campus and Hospice Business 59043 5Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 1Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 2Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank 5285 3Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 1Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 2Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 3Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs 5281 4
... McKnight Brain Institute of the University of Florida have ... diseases by plundering the secrets of regeneration from creatures ... starfish and flatworms. , Fueled by about $6 million ... "The Regeneration Project" will connect scientists who work with ...
... medical practice that an antiretroviral drug widely used to treat ... own in patients co-infected with HIV. Their findings demonstrate ... drugs used to treat the AIDS virus. , "Our results ... has been shown to be active against HIV - it ...
... snakes are born with poisonous bites they use for defense. ... , What if they could borrow a dose of poison ... That's exactly what happens in the relationship between an Asian ... of researchers funded by the National Science Foundation (NSF) Division ...
Other Biology News:Research project tackles 'regeneration' gap 2Research project tackles 'regeneration' gap 3Widely used hepatitis B drug spurs HIV drug resistance 2Widely used hepatitis B drug spurs HIV drug resistance 3Nonvenomous Asian snakes 'borrow' defensive poison from toxic toads 2
... Purity is >95%NEN Radiolabeled Ligands\n\nReceptor-related research has ... of new radiolabeled ligands selected to keep ... wide range of products and services for ... 400 state-of-the-art radioligands. If you do not ...
... DNA polymerase is an antibody-mediated ... both conventional and real-time PCR ... at a concentration of 5 ... 5,000 units polymerase, 25 ml ...
... the formation of a phosphodiester bonds between ... duplex DNA molecules or between oligonucleotides which ... at 45 - 65?. Tfi DNA Ligase ... temperatures than conventional DNA ligases, Thus, Tfi ...
... GELase™ Agarose Gel-Digesting Preparation contains a unique ... simple, quantitative recovery of intact DNA and ... gels following electrophoresis in TAE, TBE, MOPS, ... digested directly in the TAE, TBE, MOPS, ...
Biology Products: